Hellman & Friedman Capital Partners X (Parallel), L.P. files SEC Form 4 reports at Medline Inc. (MDLN). 5 SEC Form 4 filings on record going back to 2025, most recently on 1 June 2026. Most recent open-market trade: sold $46.14M of MDLN on 1 June 2026. Lifetime open-market sales: $2.65B.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Hellman & Friedman Capital Partners X (Parallel), L.P..
InsiderAlpha's records for Hellman & Friedman Capital Partners X (Parallel), L.P. go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Hellman & Friedman Capital Partners X (Parallel), L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
What is Hellman & Friedman Capital Partners X (Parallel), L.P.?
Hellman & Friedman Capital Partners X (Parallel), L.P. is an investment firm of Medline Inc. (MDLN). InsiderAlpha holds 5 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Hellman & Friedman Capital Partners X (Parallel), L.P. last file a Form 4?
The most recent primary Form 4 on record is dated 1 June 2026, one of 5 filings going back to 2025.
Has Hellman & Friedman Capital Partners X (Parallel), L.P. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($2.65B) across all tracked filings.
